Stefan Müller-Hülsbeck: The current drug-eluting stent landscape

902

In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses the progress of the IMPERIAL trial comparing the Eluvia (Boston Scientific) and Zilver PTX (Cook Medical) drug-eluting stents.

 

(Visited 366 times, 3 visits today)